Relationship Between Autophagy and Drug Resistance in Tumors

Xuan Hu1, Lu Wen2,3, Xianfeng Li1

  • 1Department of Radiotherapy, First Hospital of Shanxi Medical University, Taiyuan, China.

Insights

Multidrug resistance (MDR) in cancer is a major challenge. This study explores how autophagy, a cellular self-degradation process, influences MDR in tumor cells through molecular mechanisms.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Mechanisms

Background:

  • Multidrug resistance (MDR) in tumor cells presents a significant hurdle in cancer chemotherapy.
  • Autophagy, a fundamental cellular process of self-degradation, exhibits dual roles in cancer, potentially inhibiting or promoting its development.
  • The interplay between autophagy and drug resistance in cancer is intricate, with autophagy influencing both drug sensitivity and resistance via diverse molecular pathways.

Purpose of the Study:

  • To elucidate the complex relationship between autophagy and multidrug resistance in tumor cells.
  • To investigate the molecular mechanisms underlying autophagy's role in modulating tumor cell drug resistance.

Main Methods:

  • Literature review and analysis of existing research on autophagy and MDR.
  • Exploration of molecular pathways involved in autophagy-mediated drug resistance.
  • Synthesis of current understanding regarding autophagy's dual role in cancer progression and treatment response.

Main Results:

  • Autophagy can promote or inhibit cancer development depending on the cellular context and stage of tumorigenesis.
  • Autophagy's role in drug resistance is multifaceted, capable of enhancing resistance through certain molecular pathways while potentially increasing sensitivity through others.
  • Understanding these molecular mechanisms is crucial for developing effective therapeutic strategies.

Conclusions:

  • The relationship between autophagy and MDR is complex and context-dependent.
  • Targeting autophagy pathways presents a potential strategy for overcoming MDR in cancer therapy.
  • Further research into the molecular mechanisms is warranted to fully harness autophagy's therapeutic potential in oncology.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K